Researcher

Losen, M.R.

Assistant Professor

View graph of relations
  1. 2019
  2. Published
  3. Published
  4. Published
  5. Published
  6. 2018
  7. Published
  8. Published
  9. Published
  10. Published
  11. Published
    Verschuuren, J. J. G. M., Plomp, J. J., Burden, S. J., Zhang, W., Fillie-Grijpma, Y. E., Stienstra-van Es, I. E., ... Huijbers, M. G. (2018). Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies. Annals of the New York Academy of Sciences, 1413(1), 111-118. https://doi.org/10.1111/nyas.13543
  12. 2017
  13. Published
  14. Published
  15. Published
  16. Published
  17. Published
  18. Published
  19. 2016
  20. Published
  21. Published
  22. Published
    Kohler, S., Losen, M., Alexander, T., Hiepe, F., & Meisel, A. (2016). Myasthenia gravis: subgroup classifications. Lancet Neurology, 15(4), 356-357. https://doi.org/10.1016/S1474-4422(16)00033-8
  23. Published
    Stergiou, C., Lazaridis, K., Zouvelou, V., Tzartos, J., Mantegazza, R., Antozzi, C., ... Tzartos, S. J. (2016). Titin antibodies in "seronegative" myasthenia gravis - A new role for an old antigen. Journal of Neuroimmunology, 292, 108-115. https://doi.org/10.1016/j.jneuroim.2016.01.018
  24. Published
  25. Published
  26. 2015
  27. Published
  28. Published
    Phillips, W. D., Christadoss, P., Losen, M., Punga, A. R., Shigemoto, K., Verschuuren, J., & Vincent, A. (2015). Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis. Experimental Neurology, 270, 29-40. https://doi.org/10.1016/j.expneurol.2014.12.013
  29. Published
  30. Published
  31. Published
    Tsonis, A. I., Zisimopoulou, P., Lazaridis, K., Tzartos, J., Matsigkou, E., Zouvelou, V., ... Tzartos, S. J. (2015). MuSK autoantibodies in myasthenia gravis detected by cell based assay - A multinational study. Journal of Neuroimmunology, 284, 10-17. https://doi.org/10.1016/j.jneuroim.2015.04.015
  32. Published
  33. Published
    Bode, G. H., Pickl, K. E., Sanchez-Purra, M., Albaiges, B., Borros, S., Poetgens, A. J. G., ... Martinez-Martinez, P. (2015). Detection of Peptide-Based Nanoparticles in Blood Plasma by ELISA. PLOS ONE, 10(5), [e0126136]. https://doi.org/10.1371/journal.pone.0126136
  34. Published
  35. Published
  36. 2014
  37. Published
  38. Published
  39. Published
    Zisimopoulou, P., Evangelakou, P., Tzartos, J., Lazaridis, K., Zouvelou, V., Mantegazza, R., ... Tzartos, S. J. (2014). A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. Journal of Autoimmunity, 52, 139-145. https://doi.org/10.1016/j.jaut.2013.12.004
  40. Published
  41. Published
  42. Published
  43. Published
  44. 2013
  45. Published
  46. Published
  47. Published
  48. 2012
  49. Published
  50. Published
  51. Published
    Klooster, R., Plomp, J. J., Huijbers, M. G., Niks, E. H., Straasheijm, K. R., Detmers, F. J., ... Verschuuren, J. J. (2012). Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain, 135, 1081-1101. https://doi.org/10.1093/brain/aws025
  52. Published
  53. Published
  54. Published
  55. 2011
  56. Published
  57. Published
  58. Published
  59. Published
  60. 2010
  61. Published
  62. Published
  63. Published
  64. Published
  65. Published
    Gomez, A. M., Van den Broeck, J., Vrolix, K., Janssen, S. P., Lemmens, M. A. M., van der Esch, E., ... Losen, M. (2010). Antibody effector mechanisms in myasthenia gravis-Pathogenesis at the neuromuscular junction. Autoimmunity, 43(5-6), 353-370. https://doi.org/10.3109/08916930903555943
  66. Published
  67. 2006
  68. Published
  69. 2005
  70. Published